Needle-Free Monitoring for IVF Patient Cycles

Status unconfirmed

Conditions studied: Infertility

In brief

Salivary diagnostic testing is emerging as a less invasive, inexpensive alternative to serum analyte measurements with proven diagnostic accuracy in clinical settings. This study aims to continue analyzing aspects of the performance of salivary hormone competitive immunoassays for monitoring patient's reproductive hormone profiles in the reproductive cycle. Hormone levels will be monitored during treatment cycles for infertility.

Key facts

Study ID

NCT03162809

Run by

Boston IVF

People needed

300

Starts

2017-05-09

Expected to finish

2021-06-01

Last updated by the study team

2020-08-12

Who can join

Age: 25 and older, up to 43. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of infertility.
• Cycle start age of 25 -43 years.
• Undergoing controlled ovarian stimulation for IVF.
• All monitoring scheduled at the participating IVF facility.

You may not qualify if…

• Prior cancelled cycle due to hyperstimulation.

Where it is running

• Boston IVF — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.